Tayhan Ali, Bozhan Tayhan Esra, Şahin Büyük Damla
Department of Nursing, Faculty of Health Sciences, Manisa Celal Bayar University, Manisa, Turkey.
Department of Midwifery, Faculty of Health Sciences, Manisa Celal Bayar University, Manisa, Turkey.
Nurs Health Sci. 2025 Mar;27(1):e70039. doi: 10.1111/nhs.70039.
Regret over COVID-19 vaccine decisions is a post-pandemic phenomenon that needs further research. This mixed-method research was conducted to examine nursing-midwifery students' COVID-19 vaccine decision regret and their intention to get vaccinated in the next pandemic. The research includes quantitative and qualitative research processes. In the first phase, a quantitative (cross-sectional) study was conducted, collecting data from 602 participants who met the inclusion criteria. In the second phase, semi-structured interviews were conducted with 16 participants. Data were collected using the Decision Regret Scale and semi-structured interview form. Data were analyzed using Student's t-test, one-way anova test, and inductive content analysis, and reported using Good Reporting of a Mixed Methods Study. In the study, it was determined that 96.3% of the participants had received the COVID-19 vaccine and 50.0% regretted getting vaccinated. As a result of the analysis of qualitative data, the following themes emerged that could reveal the reasons for vaccine regret; forced compliance, a strange pandemic, unknown effects, and vaccine hesitancy. Students' experiences in the COVID-19 pandemic have the potential to increase negative attitudes towards their vaccines.
对新冠疫苗决策的后悔是一种大流行后现象,需要进一步研究。本混合方法研究旨在调查护理助产专业学生对新冠疫苗决策的后悔情况以及他们在下一次大流行中接种疫苗的意愿。该研究包括定量和定性研究过程。在第一阶段,进行了一项定量(横断面)研究,从602名符合纳入标准的参与者中收集数据。在第二阶段,对16名参与者进行了半结构化访谈。使用决策后悔量表和半结构化访谈表格收集数据。使用学生t检验、单因素方差分析和归纳性内容分析对数据进行分析,并按照混合方法研究的良好报告方式进行报告。在该研究中,确定96.3%的参与者接种了新冠疫苗,50.0%的参与者后悔接种。定性数据分析的结果出现了以下几个主题,这些主题可以揭示疫苗后悔的原因:强制依从、奇特的大流行、未知的影响以及疫苗犹豫。学生在新冠大流行中的经历有可能增加他们对疫苗的负面态度。
Psychol Health. 2024-12
Hum Vaccin Immunother. 2021-11-2
JAMA Netw Open. 2021-11-1
Front Public Health. 2023
Hum Vaccin Immunother. 2023-8-1
Immunol Res. 2023-6
JMIR Public Health Surveill. 2023-1-11